254 related articles for article (PubMed ID: 29794774)
1. Transarterial chemoembolization for unresectable hepatocellular carcinoma: A comparison of the efficacy and safety of 2 embolic agents.
Chen S; Yu W; Zhang K; Liu W; Chen Q
Medicine (Baltimore); 2018 May; 97(21):e10832. PubMed ID: 29794774
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles.
Kawai N; Sato M; Minamiguchi H; Ikoma A; Sanda H; Nakata K; Sato H; Sakaguchi H; Nakai M; Sonomura T
J Vasc Interv Radiol; 2013 Sep; 24(9):1383-90. PubMed ID: 23727419
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and Safety of Repeated Transarterial Chemoembolization Using Miriplatin-Lipiodol Suspension for Hepatocellular Carcinoma.
Matsumoto T; Ichikawa H; Imai J; Hayashi T; Tomita K; Mine T; Kojima S; Watanabe N; Hasebe T
Anticancer Res; 2017 Jun; 37(6):3183-3187. PubMed ID: 28551662
[TBL] [Abstract][Full Text] [Related]
4. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
[TBL] [Abstract][Full Text] [Related]
5. Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: Rationale, Technique, and Outcome.
Miyayama S; Matsui O
J Vasc Interv Radiol; 2016 Sep; 27(9):1269-1278. PubMed ID: 27345337
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of transcatheter arterial chemoembolization with embospheres in treatment of hepatocellular carcinoma.
Hao MZ; Lin HL; Chen QZ; Hu YB; Chen JB; Zheng JX; Zhou D; Zhang H
J Dig Dis; 2017 Jan; 18(1):31-39. PubMed ID: 27987344
[TBL] [Abstract][Full Text] [Related]
7. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
[TBL] [Abstract][Full Text] [Related]
8. Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE).
Iezzi R; Cesario V; Siciliani L; Campanale M; De Gaetano AM; Siciliano M; Agnes S; Giuliante F; Grieco A; Pompili M; Rapaccini GL; Gasbarrini A; Bonomo L;
Radiol Med; 2013 Jun; 118(4):555-69. PubMed ID: 23358819
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
[TBL] [Abstract][Full Text] [Related]
10. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization vs. radiofrequency ablation for the treatment of single hepatocellular carcinoma 2 cm or smaller.
Kim JW; Kim JH; Sung KB; Ko HK; Shin JH; Kim PN; Choi HK; Ko GY; Yoon HK; Chun SY; Gwon DI
Am J Gastroenterol; 2014 Aug; 109(8):1234-40. PubMed ID: 24935276
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: an Asian cooperative study between Japan and Korea.
Ikeda M; Arai Y; Park SJ; Takeuchi Y; Anai H; Kim JK; Inaba Y; Aramaki T; Kwon SH; Yamamoto S; Okusaka T; ;
J Vasc Interv Radiol; 2013 Apr; 24(4):490-500. PubMed ID: 23466316
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Transarterial Chemoembolization Combined with CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to the Hepatic Hilum within Milan Criteria.
Guo Y; Zhang Y; Huang J; Chen X; Huang W; Shan H; Zhu K
J Vasc Interv Radiol; 2016 Apr; 27(4):487-95. PubMed ID: 26922006
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for the benefit of triple-drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma.
He M; Li Q; Shen J; Tan G; Li Q; Lai J; Wei W; Zhang Y; Zou R; Chen M; Guo R; Shi M
Cancer Med; 2019 Aug; 8(9):4200-4213. PubMed ID: 31207163
[TBL] [Abstract][Full Text] [Related]
15. Arterial embolization of massive hepatocellular carcinoma with lipiodol and gelatin sponge.
Xie LL; Sun CJ; Li XD; Wang YH; Wang CE
Indian J Cancer; 2015 Feb; 51 Suppl 2():e49-51. PubMed ID: 25712844
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy.
Miki I; Murata S; Uchiyama F; Yasui D; Ueda T; Sugihara F; Saito H; Yamaguchi H; Murakami R; Kawamoto C; Uchida E; Kumita SI
World J Gastroenterol; 2017 Sep; 23(35):6437-6447. PubMed ID: 29085193
[TBL] [Abstract][Full Text] [Related]
17. A retrospective comparative study of epirubicin-lipiodol emulsion and cisplatin-lipiodol suspension for use with transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma.
Yodono H; Matsuo K; Shinohara A
Anticancer Drugs; 2011 Mar; 22(3):277-82. PubMed ID: 21360850
[TBL] [Abstract][Full Text] [Related]
18. Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma.
Kim DY; Ryu HJ; Choi JY; Park JY; Lee DY; Kim BK; Kim SU; Ahn SH; Chon CY; Han KH
Aliment Pharmacol Ther; 2012 Jun; 35(11):1343-50. PubMed ID: 22486716
[TBL] [Abstract][Full Text] [Related]
19. Cerebral lipiodol embolism after transarterial chemoembolization for hepatic carcinoma: a case report.
Jia ZZ; Tian F; Jiang GM
World J Gastroenterol; 2012 Aug; 18(30):4069-70. PubMed ID: 22912560
[TBL] [Abstract][Full Text] [Related]
20. Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.
Pinter M; Hucke F; Graziadei I; Vogel W; Maieron A; Königsberg R; Stauber R; Grünberger B; Müller C; Kölblinger C; Peck-Radosavljevic M; Sieghart W
Radiology; 2012 May; 263(2):590-9. PubMed ID: 22438359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
